ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - los sueros inmunes e inmunoglobulinas, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. ver secciones 4. 4 y 5.
rohipnol roche inyectable parenteral
roche farma, s.a. - flunitrazepam - excipientes: alcohol etilico (etanol),alcohol bencilico,propilenglicol - hipnÓticos y sedantes - derivados de la benzodiazepina - flunitrazepam
roche cardiac poc troponin t.
productos roche q.f.s.a. -
roche cardiac probnp+.
productos roche q.f.s.a. -
roche cardiac m myoglobin.
productos roche q.f.s.a. -
roche cardiac.
productos roche q.f.s.a. -
roche cardiac ck-mb.
productos roche q.f.s.a. -
roche cardiac.
productos roche q.f.s.a. -
roche cardiac m myoglobin.
productos roche q.f.s.a. -
tecentriq 1200 mg/ 20 ml concentrado para solucion para perfusion
roche farma (peru) s.a. - droguerÍa - atezolizumab - concentrado para solucion para perfusion - 1200 mg/20 ml - por vial 20.00 mg - - agentes antineoplÁsicos